Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis. 1982

K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga

Serum absolute free T4 (AFT4) and T3 (AFT3) concentrations were studied in 10 patients with subacute thyroiditis whose total serum T4 levels were elevated, and values were compared with those obtained in 10 patients with untreated Graves' disease, whose total serum T4 concentrations were elevated to the same level as in the former group. The mean (+/- SD) basal metabolic rate in patients with subacute thyroiditis was 16 +/- 14.8%, significantly (P less than 0.001) lower than that in patients with Graves' disease (48.7 +/- 15.7%). Serum T4-binding globulin concentrations measured by RIA were normal and did not differ from those in Graves' disease patients. The percentage of free T4 and AFT4 were both elevated in subacute thyroiditis to a degree comparable to that seen in Graves' disease. The serum total T3, serum free T3 fraction and AFT3 were also elevated, but both total T3 and AFT3 were significantly (P less than 0.05 and P less than 0.05, respectively) lower than in Graves' disease patients. Therefore, the ratios of T3 to T4 and AFT3 to AFT4 were significantly (P less than 0.01 and P less than 0.01, respectively) lower than in Graves' disease patients. These results indicate that the significantly lower basal metabolic rate and milder manifestations of thyrotoxic symptoms in subacute thyroiditis than in Graves' disease might be explained by the low ratios of T3 to T4 and AFT3 to AFT4 as well as the short duration of chemical hyperthyroidism.

UI MeSH Term Description Entries
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000510 Alpha-Globulins Serum proteins that have the most rapid migration during ELECTROPHORESIS. This subgroup of globulins is divided into faster and slower alpha(1)- and alpha(2)-globulins. Alpha-Globulin,Alpha Globulin,Alpha Globulins
D013966 Thyroiditis Inflammatory diseases of the THYROID GLAND. Thyroiditis can be classified into acute (THYROIDITIS, SUPPURATIVE), subacute (granulomatous and lymphocytic), chronic fibrous (Riedel's), chronic lymphocytic (HASHIMOTO DISEASE), transient (POSTPARTUM THYROIDITIS), and other AUTOIMMUNE THYROIDITIS subtypes. Thyroiditides
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4
D013975 Thyroxine-Binding Proteins Blood proteins that bind to THYROID HORMONES such as THYROXINE and transport them throughout the circulatory system. Thyroxine Transport Protein,Thyroxine-Binding Protein,Thyroxine Binding Protein,Thyroxine Binding Proteins
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3

Related Publications

K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
December 1987, Endocrinologia japonica,
K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
September 2016, Annals of medicine and surgery (2012),
K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
August 1983, British medical journal (Clinical research ed.),
K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
January 1993, American journal of veterinary research,
K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
February 2002, Journal of endocrinological investigation,
K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
November 1981, The Journal of clinical endocrinology and metabolism,
K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
May 1974, Metabolism: clinical and experimental,
K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
March 2006, Journal of veterinary science,
K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
September 2001, Journal of the American Veterinary Medical Association,
K Yoshida, and T Sakurada, and N Kaise, and K Kaise, and H Kitaoka, and H Fukazawa, and M Yamamoto, and S Saito, and K Yoshinaga
June 2005, Clinical chemistry,
Copied contents to your clipboard!